Role of synbiotics in the prevention of necrotizing enterocolitis in preterm neonates: a randomized controlled trial
Keywords:
Synbiotics, Necrotizing enterocolitis, Sepsis, PretermAbstract
Background: Although survival of preterm neonates has improved in the surfactant era, necrotizing enterocolitis (NEC) continues to be a major cause of mortality and morbidity. A proposed strategy for the prevention of NEC is the administration of oral synbiotics. We evaluated the role of synbiotics in reducing the incidence and severity of NEC in preterm babies.
Methods: A prospective randomized control trial was conducted in preterm neonates <34 weeks of gestation. They were randomized into two groups. The neonates in the test group were fed with synbiotic sachet with breast milk, twice daily till they reach full feeds. The neonates in the control group were fed with breast milk alone. The primary outcome was incidence and severity of NEC.
Results: 200 preterm neonates were enrolled, 100 in the test group and 100 in the control group. The demographic and clinical variables were similar in both groups. The incidence of NEC was significantly lower in the test group (2 of 100 vs. 10 of 100). The incidence of stage 2 NEC was nil in the test group but 5 in control group. There were 2 cases of severe NEC (stage 3) in the control group and none in the test group. Incidence of sepsis was also significantly lower in the test group (28 of 100 vs. 42 of 100). Other secondary outcomes like age reached full feeds and duration of hospital stay were similar in both test and control groups.
Conclusions: Synbiotics fed enterally with breast milk reduced both the incidence and severity of NEC.
References
Caplan MS. Neonatal necrotizing enterocolitis [Introduction]. Semin Perinatol. 2008;32(2):69.
Neu J, Mshvildadze M, Mai V. A roadmap for understanding and preventing necrotizing enterocolitis. Curr Gastroenterol Rep. 2008;10(5):450-7.
Luig M, Lui K; NSW & ACT NICUS Group. Epidemiology of necrotizing enterocolitis - Part II: risks and susceptibility of premature infants during the surfactant era: a regional study. J Paediatr Child Health. 2005;41(4):174-9.
Veereman-Wauters G. Neonatal gut development and postnatal adaptation. Eur J Pediatr. 1996;155(8):627-32.
Wang Y, Hoenig JD, Malin KJ, Qamar S, Petrof EO, Sun J, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3(8):944-54.
Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007;1(1):56-66.
Schwiertz A, Gruhl B, Lobnitz M, Michel P, Radke M, Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res. 2003;54(3):393-9.
Kullen MJ, Bettler J. The delivery of probiotics and prebiotics to infants. Curr Pharm Des. 2005;11:55-74.
Stenger MR, Reber KM, Giannone PJ, Nankervis CA. Probiotics and prebiotics for the prevention of necrotizing enterocolitis. Curr Infect Dis Rep. 2011;13:13-20.
Arciero JC, Ermentrout GB, Upperman JS, Vodovotz Y, Rubin JE. Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis. PLoS One. 2010;5:e10066.
Samanta M, Sarkar M, Ghosh P, Ghosh JK, Sinha MK, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight new-borns. J Trop Pediatr. 2009;55(2):128-31.
12. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115(1):1-4.
Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93(1):81-6.
Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr. 2011;65(4):434-9.
Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, Gallardo-Sarmiento RB, Garcia-Perez CS, Montaño-Rodríguez R, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm new-borns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F5-9.
Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82(2):103-8.
Kafetzis DA, Skevaki C, Costalos C. Neonatal necrotizing enterocolitis: an overview. Curr Opin Infect Dis. 2003;16(4):349-55.
